Medicus Pharma Warrant
MDCXW
6 hedge funds and large institutions have $140K invested in Medicus Pharma Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
4.52% more ownership
Funds ownership: 17.53% → 22.05% (+4.5%)
16% less capital invested
Capital invested by funds: $167K → $140K (-$27.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$34.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $57.6K | – | – | – |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $38.9K | +$34.6K | +42,400 | +100% |
|
|
PAG
3
Private Advisor Group
Morristown,
New Jersey
| $27.4K | – | – | – |
|
|
EAM
4
Empery Asset Management
New York
| $11.5K | – | – | – |
|
|
CCM
5
Connective Capital Management
Palo Alto,
California
| $3.36K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $820 | +$1.2K | +1,465 | New |
|
MDCXW Hedge Fund Activity: Q1 2026 in Review
6 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q1 2026, worth a combined $140K — down 16% from $167K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MDCXW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Anson Funds Management, adding an estimated $34.6K.
- 6 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q1 2026, up from 5 in Q4 2025.
- Funds reported $140K of Medicus Pharma Warrant stock for Q1 2026, down 16% quarter-over-quarter.
- 1 fund opened new Medicus Pharma Warrant positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest Medicus Pharma Warrant buyer in Q1 2026 was Anson Funds Management, an estimated $34.6K added.
Based on aggregated 13F filings for Q1 2026.